Cite
HARVARD Citation
Maksymowych, W. et al. (2018). Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients. Rheumatology. pp. 1390-1399. [Online].